Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Palatinose (Isomaltulose) and Metabolic Syndrome: Scientific Evidence

Palatinose, also known as isomaltulose, is a naturally occurring disaccharide carbohydrate that has attracted interest for metabolic health, particularly in the context of metabolic syndrome. Palatinose is structurally similar to sucrose, but it is digested and absorbed more slowly, resulting in a lower glycemic index and a blunted postprandial glucose and insulin response.

Several human studies and reviews support its use for improving glycemic control. For example, randomized controlled trials have demonstrated that replacing sucrose or other rapidly digestible carbohydrates with Palatinose leads to reduced postprandial blood glucose and insulin levels in healthy and diabetic subjects. These effects are relevant to metabolic syndrome, which is characterized by insulin resistance, dysglycemia, and other metabolic disturbances.

Moreover, Palatinose has been shown to promote greater fat oxidation compared to high-glycemic carbohydrates, which may be beneficial for weight management and lipid metabolism—both key factors in metabolic syndrome. However, while these mechanistic and short-term benefits are supported, there is a lack of large, long-term studies directly evaluating Palatinose’s effects on hard clinical outcomes in metabolic syndrome patients.

In summary, there is moderate scientific evidence (score 3/5) supporting Palatinose as a carbohydrate alternative that may help manage some metabolic parameters relevant to metabolic syndrome, mainly based on short-term glycemic and insulinemic improvements. More robust, long-term clinical trials are needed to further validate its clinical efficacy for this condition.

More about Palatinose
More about Metabolic Syndrome

Other ingredients used for Metabolic Syndrome

Other health conditions supported by Palatinose

Products containing Palatinose